A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, Pieterse M, Wientjens E, Seibler J, Hogervorst FB, Jonkers J.
Cancer Discov. 2013 Oct;3(10):1142-55. doi: 10.1158/2159-8290.CD-13-0094. Epub 2013 Jul 18.
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.
Zhang S, Iyer S, Ran H, Dolgalev I, Gu S, Wei W, Foster CJR, Loomis CA, Olvera N, Dao F, Levine DA, Weinberg RA, Neel BG.
Cancer Discov. 2021 Feb;11(2):362-383. doi: 10.1158/2159-8290.CD-20-0455. Epub 2020 Nov 6.
Unclassified sex cord-stromal tumors of the ovary: a report of eight cases.
Simpson JL, Michael H, Roth LM.
Arch Pathol Lab Med. 1998 Jan;122(1):52-5.
The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.
Dundr P, Hojný J, Dvořák J, Hájková N, Vránková R, Krkavcová E, Berjon A, Bizoń M, Bobiński M, Bouda J, Bui QH, Căpîlna ME, Ciccarone F, Flídrová M, Fröbe A, Grabowska K, Halaška MJ, Hausnerová J, Jedryka M, Laco J, Kalist V, Klát J, Kolníková G, Książek M, Marek R, Matěj R, Michal M, Michalová K, Ndukwe M, Němejcová K, Petróczy D, Piatnytska T, Póka R, Poprawski T, Ryś J, Sawicki W, Sharashenidze A, Stolnicu S, Stružinská I, Špůrková Z, Volodko N, Zapardiel I, Zikán M, Židlík V, Cibula D, Poncová R, Kendall Bártů M.
Lab Invest. 2025 May;105(5):104092. doi: 10.1016/j.labinv.2025.104092. Epub 2025 Feb 5.
Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP).
Acosta AM, Colecchia M, Comperat E, Cornejo KM, Gill AJ, Gupta S, Cheville JC, Idrees MT, Kao CS, Maclean F, Matoso A, Raspollini MR, Michalova K, Reyes Múgica M, Tickoo SK, Tsuzuki T, Ulbright TM, Williamson SR, Siegmund S, Sholl LM, Gonzalez-Peramato P, Berney DM.
Histopathology. 2025 Nov;87(5):660-676. doi: 10.1111/his.15482. Epub 2025 Jun 18.
Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects.
Bose M, Singh MI, Frödin M, Ejlertsen B, Sørensen CS, Rossing M.
J Clin Invest. 2025 Apr 15;135(12):e181879. doi: 10.1172/JCI181879. eCollection 2025 Jun 16.
Unclassified Mixed Germ Cell-Sex Cord-Stromal Tumor of the Ovary: An Unusual Case Report.
Saenz J, Rodriguez J, Beltran M, Medina M, Pareja R.
Cureus. 2020 Jul 23;12(7):e9350. doi: 10.7759/cureus.9350.
Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Chen GM, Kannan L, Geistlinger L, Kofia V, Safikhani Z, Gendoo DMA, Parmigiani G, Birrer M, Haibe-Kains B, Waldron L.
Clin Cancer Res. 2018 Oct 15;24(20):5037-5047. doi: 10.1158/1078-0432.CCR-18-0784. Epub 2018 Jul 3.
PTCH1::GLI1 Fusion Tumors of the Ovary: A Clinicopathologic Study of 3 Cases.
Bakkar R, Afkhami M, Balzer B, Maluf H, Song M, Moore R, Ramondetta L, Bell D, Malpica A.
Int J Gynecol Pathol. 2025 Nov 1;44(6):507-518. doi: 10.1097/PGP.0000000000001110. Epub 2025 Jul 16.
Genetic testing and familial implications in breast-ovarian cancer families.
Oosterwijk JC, de Vries J, Mourits MJ, de Bock GH.
Maturitas. 2014 Aug;78(4):252-7. doi: 10.1016/j.maturitas.2014.05.002. Epub 2014 May 9.
